News, Press Releases & Press Articles

Quotient Bioresearch Acquires Edinburgh Research Facility

Date: 18/05/2009

CAMBRIDGESHIRE, UK, 18th May 2009 – Quotient Bioresearch Limited ("Quotient"), a leading provider of drug development services, today announces that it has acquired Charles River Laboratories' (Charles River) Edinburgh clinical research facility. This represents the sixth acquisition in approximately three years for Quotient.
Download Document: QuotientClinicalAnnouncment1805091.pdf (79.4 KB)